Our current and future growth is based on the company’s five-pillar strategy comprising specialty pharmaceuticals, biosimilars, contrast media, generics and consumer healthcare products.
One of Apollo’s strategic focuses is to bring high quality pharmaceuticals from Germany to different parts of the world. Our national markets have different product ranges.
Apollo's Specialty Pharmaceuticals segment develops and markets innovative and competitive medicines
Apollo Specialty has a pipeline of high-quality biosimilar medicines to increase access to life-changing biologic therapies.
Apollo’s goal is to establish a reputation for performance and quality in contrast media.
Consumer Healthcare products – Caring for people’s health and wellbeing around the world.
Apollo develops and distributes high-quality APIs to a variety of markets around the world.
Our corporate strategy is based on quality and accountability. We recognise the critical importance of product safety in the healthcare system and have aligned Apollo’s quality policy with regulatory requirements for pharmaceutical and healthcare products. An important factor in determining the quality of pharmaceutical products is the assessment of the risk of newly discovered adverse effects of active ingredients.
Apollo's Specialty Pharmaceuticals segment develops and markets innovative and competitive medicines
Apollo Specialty has a pipeline of high-quality biosimilar medicines to increase access to life-changing biologic therapies.
Apollo’s goal is to establish a reputation for performance and quality in contrast media.
One of Apollo's key businesses is the marketing and sale of low cost drugs, commonly known as generics.
Consumer Healthcare products – Caring for people’s health and wellbeing around the world.
Apollo develops and distributes high-quality APIs to a variety of markets around the world.
